163P Combinatorial drug screen identifies therapeutic vulnerabilities of pancreatic cancer subtypes

Read full text Summarise with VIRAT
Authors: CS Storz, Hannah Jakubowsky, Christian Schneeweis, Chiara Falcomatà, Dieter Saur
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is highly lethal with few effective treatments, partly due to pronounced tumour heterogeneity and rapid drug resistance. Innovative combination therapies are required to improve clinical outcomes.

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Pancreatitis Pathology and Treatment Cancer Genomics and Diagnostics

Publication details

Journal / source
ESMO Open
Volume
11
Pages
106170–106170
Publication date
1 April 2026
Language
EN